MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517016905 A) filed by Mindset Pharma Inc., Toronto, on Feb. 26, for 'indazole derivatives as serotonergic agents useful for the treatment of disorders related thereto.'
Inventor(s) include Slassi, Abdelmalik.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The present application relates to indazole derivatives of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders or conditions by activation of ...